Paid Clinical Trials in Katy, TX
As of August 2026, 54 paid clinical trials are recruiting in Katy, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Katy offers studies at sites including Retina Consultants of Texas for conditions such as Alzheimers Disease, Crohn's Disease, Geographic Atrophy (GA), Geographic Atrophy Secondary to Age-related Macular Degeneration. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Katy
Trials by drug in Katy
Filter results
Newly added in Katy
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
52 clinical trials
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Study of DONQ52 in Active Celiac Disease
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
Device Global Registry for the IlluminOss Bone Stabilization System
Top Research Study Locations in Katy
Researchers run research studies in Katy, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Retina Consultants of Texas | Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD), Age-Related Macular Degeneration | 8 |
| Biopharma Informatic, LLC | Myositis, Overweight or Obesity, Psoriatic Arthritis | 3 |
| R & H Clinical Research | COPD, Immunoglobulin A Nephropathy (IgAN), Primary IgA Nephropathy | 3 |
| Gastro Health & Nutrition | Crohn's Disease, Ulcerative Colitis, Colitis Ulcerative | 3 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive, Systemic Lupus Erythematosus | 2 |
| Mt.Olympus Medical Research | Alzheimers Disease | 2 |
| R and H Clinical Research | Lupus Erythematosus, Systemic, Systemic Lupus Erythematosus (SLE) | 2 |
| Retina Consultants of Texas (Katy) | Macular Edema Secondary to Inflammation | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| Advanced Interventional Pain | Lumbar Spinal Stenosis | 1 |
| Artiva Investigational | IIM, Idiopathic Inflammatory Myopathies (IIMs), Myositis | 1 |
| BRCR Global - Katy | Atopic Dermatitis | 1 |
| Biopharma Informatic | Rheumatoid Arthritis | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Elyson Neighborhood | Cardiometabolic Health, Healthy Eating | 1 |
| Gulf Coast Clinical Research | Diabetic Kidney Disease (DKD) | 1 |
| Houston Orthopedic and Spine Surgery Center | Lumbar Spinal Stenosis | 1 |
| Houston Rheumatology & Arthritis Specialists - PLLC - PPDS | Sjögren's Syndrome | 1 |
| Lone Star Clinical Research - Katy | Acne | 1 |
| Medical Colleagues of Texas, LLP | Adnexal Mass, Atypical Endometrial Hyperplasia, Cervical Cancer | 1 |
| Medical Colleagues-Texas LLP | Obesity, Type 2 Diabetes | 1 |
| Memorial Hermann Hospital | Pathological Fracture, Traumatic Fracture | 1 |
| Memorial Hermann Surgery Center - Kingsland | Lumbar Spinal Stenosis | 1 |
| Nephrology Associates of Houston PLLC | Kidney Disease | 1 |
| Olympus Clinical Research | Diabetic Foot Ulcer (DFU), Lower Extremity | 1 |
Active & Upcoming Studies in Katy (2026)
Recruiting trials in Katy grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Eye & vision (10 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
- A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration · Phase 2 · Novartis Pharmaceuticals
Diabetes & metabolic (4 active studies)
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight · Phase 3 · Novo Nordisk A/S
Cardiovascular (2 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure · Phase 3 · Boehringer Ingelheim
Cancer & tumors (1 active study)
Common conditions studied in Katy
- Alzheimers Disease (2 active studies)
- Crohn's Disease (2 active studies)
- Geographic Atrophy (GA) (2 active studies)
- Geographic Atrophy Secondary to Age-related Macular Degeneration (2 active studies)
- Gout (2 active studies)
- Macular Edema Secondary to Inflammation (2 active studies)
Leading research sponsors in Katy
- Crystalys Therapeutics
- Hoffmann-La Roche
- AbbVie
- Amgen
- Biogen
Frequently asked questions
How many paid clinical trials are currently recruiting in Katy?
There are approximately 54 recruiting clinical trials in Katy, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Katy pay participants?
Most recruiting trials in Katy compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Katy?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Katy?
The most common conditions under active study in Katy include Alzheimers Disease (2), Crohn's Disease (2), Geographic Atrophy (GA) (2), Geographic Atrophy Secondary to Age-related Macular Degeneration (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Katy?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Katy on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Katy?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Katy?
Recruiting research sites in Katy include Retina Consultants of Texas, Biopharma Informatic, LLC, R & H Clinical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Katy right now?
The largest active categories in Katy are Eye & vision (10), Diabetes & metabolic (4), Cardiovascular (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.